AstraZeneca Seeks FDA Approval for Lung Cancer Drug AstraZeneca Seeks US FDA Approval for Lung Cancer Treatment With Tagrisso-Orpathys Combination AstraZeneca has submitted a New Drug Applic... September 29, 2026 Read Guide →
Summit Stock Surges on AstraZeneca’s $2B Deal Summit Therapeutics Shares Surge After AstraZeneca’s $2 Billion Investment Summit Therapeutics shares jumped more than 15% in after-hours ... September 29, 2026 Read Guide →